Search

Your search keyword '"M. Fine"' showing total 1,814 results

Search Constraints

Start Over You searched for: Author "M. Fine" Remove constraint Author: "M. Fine" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
1,814 results on '"M. Fine"'

Search Results

1. Asset and Deficit Discourses of Student Ideas in Science Formative Assessment Co-Design

2. Photosynthate translocation increases in response to low seawater pH in a coral–dinoflagellate symbiosis

3. Machine Learning For Risk Prediction After Heart Failure Emergency Department Visit or Hospital Admission Using Administrative Health Data.

4. Motor network dynamic resting state fMRI connectivity of neurotypical children in regions affected by cerebral palsy

5. BeatProfiler: Multimodal In Vitro Analysis of Cardiac Function Enables Machine Learning Classification of Diseases and Drugs

6. Right Ventricular Systolic Pressure Trajectory as a Predictor of Hospitalization and Mortality in Patients With Chronic Heart Failure

7. Comparison of Multi-chamber CMR Phenotype and Clinical Outcomes in ATTR versus AL Cardiac Amyloidosis

8. Biventricular CMR Strain-based Phenotyping for the Prediction of Cardiovascular Outcomes in Cardiac Amyloidosis

9. Resolution of Cardiac Infiltration Following Autologous Stem Cell Transplantation for AL Amyloidosis

10. Transcranial focused ultrasound to human rIFG improves response inhibition through modulation of the P300 onset latency

11. Prevalence, incidence and clinical outcomes of epicardial coronary artery disease among transthyretin amyloidosis cardiomyopathy patients

12. Database resources of the National Center for Biotechnology Information in 2023.

13. Population Immunity and Polio Eradication

15. Development and Validation of an ICU Delirium Playbook for Provider Education

16. Anderson-Fabry disease cardiomyopathy: an update on epidemiology, diagnostic approach, management and monitoring strategies

18. Amyloidosis and Carpal Tunnel Syndrome: Surgical Technique for Extended Carpal Tunnel Release with Tenosynovium and Transverse Carpal Ligament Biopsies

19. Contribution of remote M.tuberculosis infection to tuberculosis disease: A 30-year population study.

21. 4D-Flow MRI Characterization of Pulmonary Flow in Repaired Tetralogy of Fallot

23. Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE Network

24. Blood flow restriction during high-intensity interval cycling exacerbates psychophysiological responses to a greater extent in females than males

27. Responsive high-resolution air quality index mapping using model, regulatory monitor, and sensor data in real-time

29. A Vision for the Future of Quality in Echocardiographic Reporting: The American Society of Echocardiography ImageGuideEcho Registry, Current and Future States

32. Nitrogen-based lung clearance index: a valid physiological biomarker for the clinic

34. Urine Proteomics and Renal <scp>Single‐Cell</scp> Transcriptomics Implicate Interleukin‐16 in Lupus Nephritis

35. Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk

36. The Incidence and Prevalence of Cardiac Amyloidosis in a Large Community-Based Cohort in Alberta, Canada

39. Data from Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non–Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib

40. Data from Changes in 18F-Fluorodeoxyglucose and 18F-Fluorodeoxythymidine Positron Emission Tomography Imaging in Patients with Non–Small Cell Lung Cancer Treated with Erlotinib

42. Supplementary figure 1A from ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody–Drug Conjugate Treatment

44. Supplementary figure legend from ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody–Drug Conjugate Treatment

45. Data from ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody–Drug Conjugate Treatment

46. Supplementary Data from Changes in 18F-Fluorodeoxyglucose and 18F-Fluorodeoxythymidine Positron Emission Tomography Imaging in Patients with Non–Small Cell Lung Cancer Treated with Erlotinib

47. Data from A Cell Proliferation Signature Is a Marker of Extremely Poor Outcome in a Subpopulation of Breast Cancer Patients

48. Supplementary Tables S1-S4 from A Cell Proliferation Signature Is a Marker of Extremely Poor Outcome in a Subpopulation of Breast Cancer Patients

49. Supplementary Figures S1-S10 from A Cell Proliferation Signature Is a Marker of Extremely Poor Outcome in a Subpopulation of Breast Cancer Patients

Catalog

Books, media, physical & digital resources